Show simple item record

dc.contributor.authorChart Pascual, Juan Pablo
dc.contributor.authorMontero Torres, María
dc.contributor.authorOrtega, Miguel Ángel
dc.contributor.authorMar Barrutia, Lorea
dc.contributor.authorZorrilla Martínez, Iñaki
dc.contributor.authorÁlvarez Mon, Melchor
dc.contributor.authorGonzález Pinto Arrillaga, Ana María ORCID
dc.contributor.authorÁlvarez Mon, Miguel Ángel
dc.date.accessioned2024-05-13T16:34:17Z
dc.date.available2024-05-13T16:34:17Z
dc.date.issued2024-04
dc.identifier.citationJournal of Affective Disorders 351 : 649-660 (2024)es_ES
dc.identifier.issn0165-0327
dc.identifier.issn1573-2517
dc.identifier.urihttp://hdl.handle.net/10810/67928
dc.description.abstractBackground Severe mental disorders like Schizophrenia and related psychotic disorders (SRD) or Bipolar Disorder (BD) require pharmacological treatment for relapse prevention and quality of life improvement. Yet, treatment adherence is a challenge, partly due to patients' attitudes and beliefs towards their medication. Social media listening offers insights into patient experiences and preferences, particularly in severe mental disorders. Methods All tweets posted between 2008 and 2022 mentioning the names of the main drugs used in SRD and BD were analyzed using advanced artificial intelligence techniques such as machine learning, and deep learning, along with natural language processing. Results In this 15-year study analyzing 893,289 tweets, second generation antipsychotics received more mentions in English tweets, whereas mood stabilizers received more tweets in Spanish. English tweets about economic and legal aspects displayed negative emotions, while Spanish tweets seeking advice showed surprise. Moreover, a recurring theme in Spanish tweets was the shortage of medications, evoking feelings of anger among users. Limitations This study's analysis of Twitter data, while insightful, may not fully capture the nuances of discussions due to the platform's brevity. Additionally, the wide therapeutic use of the studied drugs, complicates the isolation of disorder-specific discourse. Only English and Spanish tweets were examined, limiting the cultural breadth of the findings. Conclusion This study emphasizes the importance of social media research in understanding user perceptions of SRD and BD treatments. The results provide valuable insights for clinicians when considering how patients and the general public view and communicate about these treatments in the digital environment.es_ES
dc.description.sponsorshipThis study was supported by the Instituto de Salud Carlos III (FIS-PI22/00653) and co-financed by the European Development Regional Fund “A way to achieve Europe” and Comunidad de Madrid (P2022/BMD-7321), and ProA Capital, Halekulani S.L. and MJR.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectpsychosises_ES
dc.subjectbipolar disorderes_ES
dc.subjectmachine learninges_ES
dc.subjectnatural language processinges_ES
dc.subjectsocial mediaes_ES
dc.subjectTwitteres_ES
dc.titleAreas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitteres_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by- nc/4.0/)es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0165032724002532es_ES
dc.identifier.doi10.1016/j.jad.2024.01.234
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-
nc/4.0/)
Except where otherwise noted, this item's license is described as © 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by- nc/4.0/)